PG
FMI

PEAK6 Group’s Foundation Medicine, Inc. FMI Stock Holding History

PEAK6 Group’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,900
Closed -$1.36M – 5307
2017
Q4 		$1.36M Buy
+19,900
New +$1.03M 0.01% 1690
2017
Q1 		– Sell
-6,500
Closed -$115K – 5409
2016
Q4 		$115K Buy
6,500
+4,500
+225% +$97K ﹤0.01% 3783
2016
Q3 		$47K Buy
+2,000
New +$45.4K ﹤0.01% 3911
2016
Q2 		– Sell
-32,500
Closed -$591K – 5084
2016
Q1 		$591K Buy
32,500
+15,200
+88% +$245K ﹤0.01% 2130
2015
Q4 		$364K Buy
17,300
+16,300
+1,630% +$314K ﹤0.01% 2911
2015
Q3 		$18K Buy
1,000
+500
+100% +$12.5K ﹤0.01% 4898
2015
Q2 		$17K Sell
500
-9,500
-95% -$382K ﹤0.01% 4825
2015
Q1 		$481K Buy
+10,000
New +$454K ﹤0.01% 2588

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PEAK6 Group's FMI Position: Q1 2017 in Review

PEAK6 Group sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 5,731 shares — an estimated $101K sold.

PEAK6 Group first reported a position in FMI in Q4 2013 and held it in 8 quarters. The position peaked at $9.44M in Q4 2013. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • PEAK6 Group reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 5,731 Foundation Medicine, Inc. shares in Q1 2017, an estimated $101K.
  • PEAK6 Group first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 8 quarters.
  • PEAK6 Group's Foundation Medicine, Inc. position peaked at $9.44M in Q4 2013.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.